Search

Search Results
Results 2621 - 2630 of 8508 for Skin Cancer
  • News - 31 Jan 2005
    The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the...
  • News - 13 Jan 2005
    There is an alarming ignorance about cancer and how to reduce the risk of the disease which is Britain's biggest killer – a special survey reveals today.
  • News - 23 Sep 2004
    Drinking a glass of red wine a day may cut a man's risk of prostate cancer in half, and the protective effect appears to be strongest against the most aggressive forms of the disease
  • Drug - 17 Dec 2025
    Consumer Medicine Information (CMI) about Xelabine intended for persons living in Australia.
  • News - 15 Dec 2025
    In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the immune system's ability to fight against a tumor.
  • Drug - 10 Dec 2025
    Consumer Medicine Information (CMI) about Piqray intended for persons living in Australia.
  • Drug - 5 Nov 2025
    Consumer Medicine Information (CMI) about DBL Carboplatin Injection intended for persons living in Australia.
  • News - 21 Oct 2025
    From probiotic pills to skincare products to dedicated meal plans, the microbiome is all the rage in the health and wellness space.
  • Drug - 2 Oct 2025
    Consumer Medicine Information (CMI) about Norvir intended for persons living in Australia.
  • Drug - 1 Oct 2025
    Consumer Medicine Information (CMI) about Premarin intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.